Shuttle Pharmaceuticals Holdings, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 401 PROFESSIONAL DRIVE, GAITHERSBURG, MD, 20879
Mailing Address 401 PROFESSIONAL DRIVE, GAITHERSBURG, MD, 20879
Phone (240) 403-4212
Fiscal Year End 1231
EIN 000000000
Financial Overview
FY2024
-$6.59M
Net Income
$7.68M
Stockholders' Equity
$2.58M
Cash & Equivalents
$-3.19
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-1/A IPO registration amendment | February 11, 2026 | View on SEC |
| S-1 IPO registration statement | February 11, 2026 | View on SEC |
| 8-K Current report of material events | February 2, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
| 3 Initial insider ownership report | January 12, 2026 | View on SEC |
| 8-K Current report of material events | December 29, 2025 | View on SEC |
| S-1/A IPO registration amendment | December 11, 2025 | View on SEC |
| 8-K Current report of material events | November 28, 2025 | View on SEC |
| 8-K Current report of material events | November 26, 2025 | View on SEC |
| 8-K Current report of material events | November 21, 2025 | View on SEC |
Material Events
8-K Acquisition December 29, 2025
High Impact
- Shuttle Pharmaceuticals issued 320,496 new common shares to 1542770 BC Ltd. as an accelerated payment.
- This share issuance covers a portion of the 'First Installment Payment' for an ongoing asset acquisition.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.